AMH and cancer: Further complexity of interpreting AMH as a prognostic marker arises from the diverse fertility preservation methods (e.g., cryopreserved embryos, oocytes, and tissues), cancer types, and chemotherapy regimens, all of which impact AMH levels and reproductive outcomes.